Skip to main content

CANNAPHARMARX, INC.

corporate_fare Company Profile

CANNAPHARMARX, INC.

CPMD·OTC·Life Sciences·CIK 0001081938

CANNAPHARMARX, INC. specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The company, originally incorporated in Colorado in August 1998 as Network Acquisitions, Inc., has evolved to focus on producing high-quality medical cannabis and craft products. Its principal executive office is located at 4439 Township Rd 304, Mountain View County, Alberta, Canada T0M 0R0. On January 6, 2022, CANNAPHARMARX, INC. entered into a 20-year operating lease for a 55,000 square foot facility in Cremona, Alberta, Canada. During 2022, this facility was recommissioned into an indoor cannabis farm with 10 growing rooms and one drying and packing room. Currently, the facility operates six of these growing rooms and one drying and packing room. The company plans to increase capacity over the next one to two years to open a second drying and packing room and operate all 10 growing rooms. CANNAPHARMARX, INC. received an operating license from Health Canada on December 9, 2022, and a cannabis license from the Canada Revenue Agency ("CRA") on December 22, 2022. The company commenced cannabis production during the year ended December 31, 2023. It aims to grow by increasing production capacity at the Cremona facility to support sales of cannabis to European markets, specifically Germany and Israel. To achieve this, the company intends to increase the number of growing rooms from six to 10 over the next one to two years, open a second drying and packing room, and build a sales network in Germany and Israel. The company is also applying for European Union Good Manufacturing Practices ("EU-GMP") certification. Currently, its cannabis is sent to a third-party European intermediary for packaging to comply with EU-GMP standards.

CANNAPHARMARX, INC. (OTC:CPMD) is a publicly traded company in the Life Sciences sector. Wiseek monitors CPMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • CannaPharmaRx Discloses Going Concern Doubt, Material Weakness, and Multiple Defaults

monitoring Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.36M
Net Income
-$11.13M
Diluted EPS
-$0.02
Op. Cash Flow
-$789.1K
Free Cash Flow
-$794.62K
Gross Profit
-$2.08M
Operating Income
-$3.35M
Cash & Equivalents
$1.8K
Debt / Equity
0.00×
Net Margin
-8.17×
Shares Outstanding
662.5M sh
Source: 10-K · filed 2026-03-31 · accession 0001654954-26-003108
$0
52-week range $0 – $0.01
Market cap
$2.51M
Volume
1.5K (0.0× avg)
3-mo avg 146.4K
Price snapshot as of 2026-05-20 21:40 UTC (Market snapshot (POST))

show_chartPrice Chart

Loading chart...

feed CPMD - Latest Insights

CPMD
May 20, 2026, 3:52 PM EDT
Filing Type: 10-Q
Importance Score:
9